The Research Network

Recent papers from The Research Network

1. C92, a proton channel-blocking allosteric STING agonist generates robust antitumor activityJournal for ImmunoTherapy of Cancer · 2026
2. Efficacy and safety of LEVI-04 in patients with osteoarthritis of the knee: a randomised, double-blind, placebo-controlled, phase 2 trialThe Lancet · 2026
3. Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmissionScience Advances · 2024
4. V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1–infected, treatment-experienced persons receiving optimized background regimensAntiviral chemistry & chemotherapy · 2021
5. Highly prevalent Russian HIV-1 V3-loop sequence variants are susceptible to maravirocAntiviral chemistry & chemotherapy · 2021
6. The APOE ∗ 3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic AtherosclerosisJournal of Diabetes Research · 2019
7. Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trialsAntiviral chemistry & chemotherapy · 2019
8. Clonal analysis of HIV-1 genotype and function associated with virologic failure in treatment-experienced persons receiving maraviroc: Results from the MOTIVATE phase 3 randomized, placebo-controlled trialsPLoS ONE · 2018
9. Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout MiceJournal of Diabetes Research · 2016
10. Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 CoreceptorJournal of Virology · 2015
11. Maraviroc – A CCR5 Antagonist for the Treatment of HIV-1 InfectionFrontiers in Immunology · 2015
12. Efficacy and Safety of Lersivirine Versus Etravirine for the Treatment of HIV-1 Infection in Patients with Prior Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Use and Evidence of NNRTI Resistance: A Randomized Phase 2B TrialHIV Clinical Trials · 2014
13. Development and Characterization of a Long-Term Murine Model of Streptococcus pneumoniae Infection of the Lower AirwaysInfection and Immunity · 2014
14. An exploratory survey measuring stigma and discrimination experienced by people living with HIV/AIDS in South Africa: the People Living with HIV Stigma IndexBMC Public Health · 2014
15. Precision measurement of the growth rate and mechanism of ibuprofen {001} and {011} as a function of crystallization environmentCrystEngComm · 2014
16. Copper-catalysed reductive amination of nitriles and organic-group reductions using dimethylamine boraneRSC Advances · 2014
17. CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous deliverymAbs · 2013
18. The 3 prime paradigm of the miR-200 family and other microRNAsEpigenetics · 2011
19. Aromatic chloride to nitrile transformation: medicinal and synthetic chemistryMedChemComm · 2010